N-Acetyl Semax Amidate / N-Acetyl Selank Amidate Blend 10ml (30mg/30mg)

Selank and Semax, both synthetic analogues of endogenous peptides, have been extensively studied for their effects on the central nervous system. Selank, derived from the immunomodulatory peptide tuftsin, has been shown to modulate the expression of neurotrophic factors such as BDNF and NGF, which play crucial roles in neuronal growth, survival, and plasticity. Additionally, Selank exhibits anxiolytic effects by regulating serotonin and norepinephrine levels in the brain, making it a promising candidate for the study of anxiety disorders and stress resilience.

Semax, a modified version of ACTH fragments, has been investigated for its neuroprotective and cognitive-enhancing properties. It has been found to stimulate the expression of BDNF and NGF, promoting neurogenesis and protecting against neuronal damage. Semax also modulates neurotransmitter systems, including acetylcholine, dopamine, and serotonin, which are involved in various cognitive functions such as memory, attention, and learning. Furthermore, Semax has been shown to improve cerebral blood flow, ensuring optimal oxygen and nutrient supply to the brain.

The intranasal administration of the Selank and Semax blend allows for rapid absorption of the peptides into the bloodstream and direct access to the central nervous system, bypassing the gastrointestinal tract and first-pass metabolism. This targeted delivery method enables researchers to investigate the immediate and long-term effects of these peptides on brain function and behavior

The Selank and Semax blend nasal spray offers several potential benefits for research in the fields of neuroscience, cognitive enhancement, and mental health:

• Cognitive enhancement: Researchers can investigate the synergistic effects of Selank and Semax on various cognitive domains, including memory, learning, attention, and executive functions.

• Anxiolytic effects: The blend provides an opportunity to study the anxiolytic properties of Selank and its potential as a novel treatment for anxiety disorders and stress-related conditions.

• Neuroprotection: The neuroprotective effects of Semax can be explored in the context of neurodegenerative disorders, brain injury, and age-related cognitive decline.

• Neuroplasticity: The impact of the Selank and Semax blend on neuroplasticity, including neurogenesis, synaptogenesis, and dendritic remodeling, can be investigated to elucidate the mechanisms underlying cognitive enhancement and brain repair.

• Neurotransmitter modulation: Researchers can study how the blend influences various neurotransmitter systems, such as serotonin, dopamine, and acetylcholine, and its implications for mood regulation, motivation, and cognitive processing.

• Translational research: The nasal spray formulation allows for easy administration in both preclinical and clinical settings, facilitating the translation of research findings from animal models to human studies.

Based on available research, Selank and Semax are generally well-tolerated, with few reported adverse effects. However, as with any investigational compound, potential side effects should be carefully monitored and documented in research settings. These may include:

• Nasal irritation: Some subjects may experience mild nasal discomfort, dryness, or congestion due to the intranasal administration.

• Headache: In rare cases, participants may report headaches following the use of the Selank and Semax blend.

• Allergic reactions: Although uncommon, some individuals may develop an allergic response to the peptides or other ingredients in the nasal spray formulation.

The Selank and Semax blend nasal spray represents a promising research tool for investigating the synergistic effects of these two synthetic neuropeptides on cognitive function, emotional regulation, and brain health. By combining the anxiolytic and cognitive-enhancing properties of Selank with the neuroprotective and neuroplastic effects of Semax, this innovative formulation offers a unique approach to studying the complex interplay between neuropeptides, neurotransmitters, and brain function. The intranasal delivery method ensures targeted administration and rapid absorption, allowing for efficient investigation of the blend's effects on various cognitive domains and neurobiological processes. As research continues to unravel the potential benefits and underlying mechanisms of Selank and Semax, this nasal spray blend provides a valuable platform for advancing our understanding of cognitive enhancement, anxiety disorders, and neuroprotection, ultimately paving the way for the development of novel therapeutic strategies in the field of neuroscience and mental health research.

• Kolik LG, Nadorova AV, Antipova TA, Kruglov SV, Kudrin VS, Durnev AD. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med. 2019 Sep;167(5):641-644. doi: 10.1007/s10517-019-04588-9. Epub 2019 Oct 17. PMID: 31625062.

• Sciacca MFM, Naletova I, Giuffrida ML, Attanasio F. Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. ACS Chem Neurosci. 2022 Feb 16;13(4):486-496. doi: 10.1021/acschemneuro.1c00707. Epub 2022 Jan 26. PMID: 35080861; PMCID: PMC8855339.

• Filippenkov IB, Stavchansky VV, Glazova NY, Sebentsova EA, Remizova JA, Valieva LV, Levitskaya NG, Myasoedov NF, Limborska SA, Dergunova LV. Antistress Action of Melanocortin Derivatives Associated with Correction of Gene Expression Patterns in the Hippocampus of Male Rats Following Acute Stress. Int J Mol Sci. 2021 Sep 17;22(18):10054. doi: 10.3390/ijms221810054. PMID: 34576218; PMCID: PMC8469576.

• Stavchansky VV, Filippenkov IB, Remizova JA, Denisova AE, Mozgovoy IV, Gubsky LV, Myasoedov NF, Andreeva LA, Limborska SA, Dergunova LV. Insight into Glyproline Peptides' Activity through the Modulation of the Inflammatory and Neurosignaling Genetic Response Following Cerebral Ischemia-Reperfusion. Genes (Basel). 2022 Dec 16;13(12):2380. doi: 10.3390/genes13122380. PMID: 36553646; PMCID: PMC9777888.

• Kasian A, Kolomin T, Andreeva L, Bondarenko E, Myasoedov N, Slominsky P, Shadrina M. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017;2017:5091027. doi: 10.1155/2017/5091027. Epub 2017 Feb 9. PMID: 28280289; PMCID: PMC5322660.

• Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016 Feb 18;7:31. doi: 10.3389/fphar.2016.00031. PMID: 26924987; PMCID: PMC4757669.

• Filatova E, Kasian A, Kolomin T, Rybalkina E, Alieva A, Andreeva L, Limborska S, Myasoedov N, Pavlova G, Slominsky P, Shadrina M. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Front Pharmacol. 2017 Feb 28;8:89. doi: 10.3389/fphar.2017.00089. PMID: 28293190; PMCID: PMC5328971.

• Dergunova LV, Filippenkov IB, Limborska SA, Myasoedov NF. Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries. Genes (Basel). 2023 Apr 22;14(5):953. doi: 10.3390/genes14050953. PMID: 37239313; PMCID: PMC10218113.